October 14th, 2026Iberdomide Regimen Cuts RRMM Progression Risk by 51%, Trial FindsThese phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.Read more
October 15th, 2026Sjögren Disease Extends Beyond Dry Eyes, Dry Mouth: Steven Carsons, MDSjögren disease involves far more than dry eyes and mouth, and variable symptoms plus multispecialty testing delay diagnosis, says Steven Carsons, MD.Read more
October 14th, 2026MASH Outcomes Hinge on Risk Stratification, Coverage: Zobair Younossi, MDEarly MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.Read more
October 13th, 2026Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular DiseaseAt a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.Read more
October 18th, 2026Income, Education NHL Mortality Gaps Widened in Canada in 2 DecadesNon-Hodgkin lymphoma mortality trends impact lower-income, less-educated communities, highlighting health disparities and needs for health equity.Read more
October 17th, 2026Automated HCV Surveillance Shows Promise But Needs ValidationSaTScan detects an acute HCV outbreak cluster in California, showing the potential of automated surveillance, though real-time testing is needed.Read more
October 16th, 2026Genetic Analysis Links Insomnia Liability to Higher Inflammation MarkerGenetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.Read more
October 16th, 2026Proinflammatory Diets Linked to Higher MASLD, MetALD MortalityProinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.Read more